Wednesday, July 8, 2026

Drug profile · INN

gabapentin encarbil

gabapentin encarbil (GABAPENTIN ENCARBIL) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gabapentin encarbil
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

gabapentin encarbil (GABAPENTIN ENCARBIL) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN gabapentin encarbil
Brand GABAPENTIN ENCARBIL
Mechanism Voltage-gated calcium channel modulator
Target Voltage-gated calcium channel
Route ORAL
Formulation TABLET, EXTENDED RELEASE

Mechanism of action

Voltage-gated calcium channel modulator

Primary target: Voltage-gated calcium channel

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. gabapentin Voltage-gated calcium channel modulator
  2. pregabalin Nervous system (N02)
  3. bepridil hydrochloride Voltage-gated calcium channel blocker
  4. gabapentin enacarbil Voltage-gated calcium channel modulator

Frequently asked questions

What is gabapentin encarbil?

gabapentin encarbil (GABAPENTIN ENCARBIL) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for gabapentin encarbil?

GABAPENTIN ENCARBIL is a marketed brand name for gabapentin encarbil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gabapentin encarbil?

gabapentin encarbil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.